tiprankstipranks
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
US Market
UPC
Universe Pharmaceuticals
RESEARCH TOOLSreports
Want to see UPC full AI Analyst Report?

Universe Pharmaceuticals (UPC) Income Statement

212 Followers

Universe Pharmaceuticals Income Statement

Last quarter (Q4 2025), Universe Pharmaceuticals's total revenue was $8.71M, a decrease of -37.10% from the same quarter last year. In Q4, Universe Pharmaceuticals's net income was $-387.30K. See Universe Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Revenue
$ 17.86M$ 23.02M$ 32.31M$ 40.14M$ 47.98M
Gross Profit
$ 6.30M$ 6.07M$ 10.32M$ 21.89M$ 25.33M
Operating Expenses
$ 9.22M$ 14.09M$ 13.84M$ 28.91M$ 11.74M
Depreciation and Amortization
$ 517.43K$ 485.73K$ 508.79K$ 533.95K$ 446.88K
EBITDA
$ -2.92M$ -7.36M$ -3.18M$ -6.40M$ 14.20M
Operating Income
$ -2.92M$ -8.02M$ -3.53M$ -7.02M$ 13.59M
Other Income/Expenses
$ -756.14K$ -100.75K$ -413.77K$ -545.35K$ 57.51K
Pretax Income
$ -3.67M$ -8.12M$ -3.94M$ -7.98M$ 13.65M
Net Income
$ -3.67M$ -8.73M$ -6.16M$ -8.74M$ 11.32M
Per Share Metrics
Basic EPS
$ -1.06K$ -1.44K$ -1.04K$ -1.48K$ 2.15K
Diluted EPS
$ -1.06K$ -1.44K$ -1.04K$ -1.48K$ 2.15K
Weighted Average Shares Outstanding
 3.48K 6.08K 5.92K 5.92K 5.27K
Weighted Average Shares Outstanding (Diluted)
 3.48K 6.08K 5.92K 5.92K 5.27K
Currency in USD

Universe Pharmaceuticals Earnings and Revenue History